Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues

Current Opinion in Lipidology

Volumn 13, Issue 3, 2002, Pages 267-272

  Contreras, Miguel A ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LITHIUM; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; ACYL COENZYME A DESATURASE; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING COMPETITION; BRAIN TISSUE; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME REGULATION; ESTERIFICATION; FATTY ACID DESATURATION; FATTY ACID SYNTHESIS; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; REVIEW; ANIMAL; BIOSYNTHESIS; BRAIN; GENETICS; METABOLISM;

ANIMAL; BRAIN; DOCOSAHEXAENOIC ACIDS; ESTERIFICATION; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMAN; MODELS, ANIMAL; ANIMALS; FATTY ACIDS, OMEGA-6; HUMANS;

EID: 0035985714     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200206000-00006     Document Type: Review

References (53)

1. The role of docosahexaenoic acid in retinal function
2. Mechanisms of action of docosahexaenoic acid in the nervous system
3. Essential fatty acids in visual and brain development
4. Arachidonic acid as a bioactive molecule
5. Regulated formation of eicosanoids
6. Sources of eicosanoid precursor fatty acid pools in tissues
7. Health benefits of docosahexaenoic acid (DHA)
8. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells
9. Polyunsaturated fatty acids are potent neuroprotectors
10. Inhibition of neuronal apoptosis by polyunsaturated fatty acids
11. Modulation of human immune and inflammatory responses by dietary fatty acids
12. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
13. Restoring the DHA levels in the brains of Zellweger patients
14. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria
15. Receptor-mediated signaling pathways: Potential targets of modulation by dietary fatty acids
16. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity
17. Eicosapentaenoic acid (EPA): An antiinflammatory omega-3 fat with potential clinical applications
18. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain
19. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats
20. Metabolism of highly unsaturated n-3 and n-6 fatty acids
21. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis
22. Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids
23. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders
24. Peroxisomal straight-chain acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis
25. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid
26. Phospholipid fatty acid remodeling in mammalian cells
27. Intracellular unesterified arachidonic acid signals apoptosis
28. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency
29. Dynamics of docosahexaenoic acid metabolism in the central nervous system: Lack of effect of chronic lithium treatment
30. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat. Level of n-6 fatty acids as another critical factor
31. Nutritional and biochemical evidences of acyl interaction with respect to essential polyunsaturated fatty acids
32. Olfactory discrimination deficits in n-3 fatty acid-deficient rats
33. Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids
34. 6 desaturases on multiple n-3 and n-6 polyunsaturated fatty acids
35. 6-desaturase
36. 6 fatty acid desaturases in two human cell lines
37. 6-desaturase deficiency in human skin fibroblasts
38. 6 activities
39. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum
40. Tissue levels of polyunsaturated fatty acids during early human development
41. Identification and characterization of an enzyme involved in the elongation of n-6 and n-3 polyunsaturated fatty acids
42. 5-desaturase involved in the biosynthesis of arachidonic acid
43. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers
44. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus
45. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease
46. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
47. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial
48. Protein kinase inhibition by omega-3 fatty acids
49. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect
50. Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes
51. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro
52. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling
53. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain